Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 284.87M | 226.47M | 337.61M | 331.86M | 222.99M |
Gross Profit | 172.33M | 136.82M | 208.93M | 208.13M | 135.57M |
EBITDA | -100.53M | -129.75M | -54.32M | -14.63M | -49.20M |
Net Income | -117.13M | -169.42M | -65.39M | -26.41M | -59.79M |
Balance Sheet | |||||
Total Assets | 688.97M | 657.65M | 710.20M | 657.54M | 573.28M |
Cash, Cash Equivalents and Short-Term Investments | 250.26M | 219.93M | 206.86M | 171.04M | 440.71M |
Total Debt | 5.26M | 5.34M | 8.64M | 11.71M | 10.44M |
Total Liabilities | 127.56M | 97.78M | 104.11M | 110.37M | 98.30M |
Stockholders Equity | 561.41M | 559.87M | 606.09M | 547.18M | 474.98M |
Cash Flow | |||||
Free Cash Flow | 23.45M | 7.05M | 29.04M | 29.12M | 25.86M |
Operating Cash Flow | 33.84M | 19.02M | 44.09M | 38.80M | 30.80M |
Investing Cash Flow | -40.53M | 7.84M | -107.30M | -119.55M | -31.32M |
Financing Cash Flow | 6.40M | 4.51M | 5.70M | 10.53M | 10.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $4.29B | 35.62 | 24.82% | 1.39% | 32.63% | 46.16% | |
70 Outperform | $2.60B | 32.21 | 10.16% | 2.60% | 10.78% | 58.82% | |
66 Neutral | $3.19B | ― | -9.17% | ― | -20.08% | -218.29% | |
60 Neutral | $4.43B | ― | -93.41% | ― | 13.83% | 88.14% | |
59 Neutral | $2.80B | ― | -18.35% | ― | 44.54% | 41.55% | |
57 Neutral | $815.27M | 11.36 | -16.80% | 2.65% | 10.29% | -42.67% | |
52 Neutral | $4.29B | ― | -14.77% | ― | 2.16% | -55.38% |
On June 4, 2025, Ambarella, Inc. held its 2025 Annual Meeting of Shareholders, with approximately 85.05% of outstanding shares represented. During the meeting, three Class I directors were elected to serve until the 2028 annual meeting, and the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending January 31, 2026, was ratified. Additionally, shareholders approved the executive compensation on a non-binding, advisory basis.
The most recent analyst rating on (AMBA) stock is a Buy with a $90.00 price target. To see the full list of analyst forecasts on Ambarella stock, see the AMBA Stock Forecast page.